NCT00463476View on ClinicalTrials.gov

Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine

PHASE4CompletedINTERVENTIONAL

Enrollment

305

Participants

Timeline

Start Date

July 9, 2007

Primary Completion Date

November 1, 2007

Study Completion Date

October 2, 2008

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL

Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine (LJEV)

Manufactured by Chengdu Institute of Biological Products (CDIBP), Chengdu, China; batch 200611A078-1. Administered subcutaneously in the right upper arm using 23 gauge needles.

Trial Locations (3)

Unknown

Homagama MOH Division Medical Office, Homagama

Kolonnawa MOH Division Medical Office, Kolonnawa

Moratuwa MOH Division Medical Office, Moratuwa

All Listed Sponsors

lead

PATH

OTHER

NCT00463476 - Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine | Biotech Hunter | Biotech Hunter